US 9725722
Modulation of TMPRSS6 expression
granted A61KA61K31/713A61K45/06
Quick answer
US patent 9725722 (Modulation of TMPRSS6 expression) held by Ionis Pharmaceuticals, Inc. expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Aug 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K31/713, A61K45/06